DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL (BNP-PL)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03959748|
Recruitment Status : Recruiting
First Posted : May 22, 2019
Last Update Posted : May 22, 2019
The BNP-PL is a multicenter, observational study in which patients are prospectively followed in order to investigate clinical course and management of pulmonary hypertension in Poland.
All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension confirmed in right heart catheterization, will be eligible to participate in the study.
|Condition or disease|
|Chronic Thromboembolic Pulmonary Hypertension Pulmonary Arterial Hypertension|
The BNP-PL Registry is an initiative of the Polish Cardiac Society Task Force for Pulmonary Vascular Diseases This study is conducted by the Polish Cardiac Society. All centers of pulmonary hypertension in Poland which are accredited by the National Health Fund have been invited to join the study. The data is administrated by the Jagiellonian University Medical College on the basis of an agreement between the Polish Cardiac Society, Jagiellonian University Medical College and pulmonary hypertension centres.
The goal is to describe current practice and outcomes in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
The data collection will have no impact on the way the patient is diagnosed and treated.
Collection of data on patients with pulmonary hypertension is carried out via the electronic platform.
No personal data is entered into the project database.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||3000 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL|
|Actual Study Start Date :||March 1, 2018|
|Estimated Primary Completion Date :||February 28, 2023|
|Estimated Study Completion Date :||February 28, 2028|
Patients with pulmonary arterial hypertension who are at least 18 years old at study entry
Patients with pulmonary arterial hypertension who are at least 3 months old and are less than 18 years old at study entry
Patients with chronic thromboembolic pulmonary hypertension who are at least 18 years old at study entry
- Mortality [ Time Frame: Since enrollment until at least 5 years. ]The number of patients who die during the follow-up period
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03959748
|Contact: Grzegorz Kopeć||+48 12 614 33 email@example.com|
|Contact: Magdalena Studnicka||+48 firstname.lastname@example.org|
|Krakowski Szpital Specjalistyczny im. Jana Pawła II||Recruiting|
|Kraków, Poland, 31-202|
|Contact: Grzegorz Kopeć +48 126143399 email@example.com|
|Principal Investigator:||Grzegorz Kopeć, MD, Phd||Krakowski Szpital Specjalistyczny im. Jana Pawła II|